CP
TDOC icon

Castleview Partners’s Teladoc Health TDOC Stock Holding History

Castleview Partners’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-22
Closed -$215 – 881
2024
Q2 		$215 Buy
+22
New +$268 ﹤0.01% 880
2023
Q3 		– Sell
-20
Closed -$506 – 762
2023
Q2 		$506 Hold
20
– – ﹤0.01% 661
2023
Q1 		$518 Hold
20
– – ﹤0.01% 642
2022
Q4 		$473 Hold
20
– – ﹤0.01% 584
2022
Q3 		$1K Buy
+20
New +$702 ﹤0.01% 599

Other funds holding TDOC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Castleview Partners's TDOC Position: Q3 2024 in Review

Castleview Partners sold out of Teladoc Health (TDOC) in Q3 2024, closing a stake of 22 shares — an estimated $215 sold.

Castleview Partners first reported a position in TDOC in Q3 2022 and held it in 5 quarters. The position peaked at $1K in Q3 2022. 366 funds tracked by Wall St. Rank hold TDOC as of Q3 2024.

  • Castleview Partners reported no remaining Teladoc Health position as of Q3 2024 after selling out during the quarter.
  • Castleview Partners sold 22 Teladoc Health shares in Q3 2024, an estimated $215.
  • Castleview Partners first reported a position in Teladoc Health in Q3 2022 and held it in 5 quarters.
  • Castleview Partners's Teladoc Health position peaked at $1K in Q3 2022.
  • 366 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2024.

Based on Castleview Partners's 13F filing for Q3 2024, filed 9 Oct 2024.